"We are driven by making the complex simple and getting things done."
Passionate about science and technology, we immediately envisioned the potential of non-invasive, quantitative imaging in Life Sciences. That's when we met Professor Frank Dubois, a scientist specialized in digital holography from the "Université Libre de Bruxelles" (ULB).
The Professor and his colleague, Dr. Yourassowsky, had spent more than a decade on fundamental research to prove the reliability and stability, even in harsh environment of the light-based Digital Holographic Microscopy. Two scientific experiments were even successfully completed on board the International Space Station (ISS).
We were fascinated by this promising technology and how it could simplify the way scientists perform day-to-day analytics. In December 2009, Ovizio Imaging Systems was born.
We commercialize our technology via global partners. In 2012, we entered into a long-term global marketing and distribution agreement with Applikon Biotechnology for the iLine F microscope, designed for Bio Processing market. Our "go-to-market" package for partners includes a joint business development plan, marketing materials, sales methodology and product training. In addition, we are scaled for rapid prototyping of devices for OEM partners. Our OEM package includes engineering and business development support services.
Our initial focus is on the Life Sciences Bio-Processing segment and the Life Sciences R&D market. Recently Ovizio has had a major technological breakthrough drastically reducing cost, size and improving quality of our platform technology allowing us to enter the diagnostics market by using our devices as a disruptive platform for point of care diagnostics.
Supported by local authorities and several venture funds, we were able to offer the first commercial version of our instruments less than one year after starting up. The Brussels-Capital Region, through INNOVIRIS (The Brussels Institute for Research and Innovation) awarded several grants to OVIZIO to start development of the first versions. The company secured funding from the founders, the SRIB (Brussels Regional Investment Company), Theodorus II (venture capital fund of the ULB), Nausicaa Ventures, Sherpa Invest II and several private investors.
Today, innovation is at the heart of our team. We continue to explore new fields of applications that include water quality control and food industry, with multiple ongoing R&D programs. This story has only just started.